跳至主要内容
临床试验/IRCT20210416050990N1
IRCT20210416050990N1已完成3 期

The assessment of effect of Rosuvastatin use on reduce of inflammatory markers in patients with venous thromboembolism

Shahid Beheshti University of Medical Sciences0 个研究点目标入组 220 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
220

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20 years 至 75 years(—)
性别
All

入选标准

  • patients with venous thromboembolism
  • In the age range of 20-75 years

排除标准

  • History of inflammatory disease such as antiphospholipid syndrom
  • History of hematologic disorders that influence on lymphocyte, neutrophil and platetet
  • History of regular use of anticoagulant drugs ( valvular heart disease..) or use of anticoagulant in recent one year
  • Use of statins or fibrate or ezetymab
  • History of heart failure
  • history of coagulopathy
  • History of vein thromboembolism
  • History of cancer
  • Kidney disease under dialysis
  • Liver disease

研究者

相似试验

The assessment of effect of Rosuvastatin use in... | 临床试验